talazoparib,enzalutamide,rucaparib,abiraterone
pfizer,astellas,clovis oncology
['rucaparib', 'brca', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talazo']
fabulous start to #gu23 with excellent presentations by and on parp inhibitors in mcrpc. talazoparib + enza shows rpfs benefit in 1 line mcrpc. caution on rates of anemia! rucaparib showed benefit mainly in brca1/2 altered mcrpc published 
Associate Professor, Chief of Genitourinary Medical Oncology,                                      Miami Cancer Institute, Baptist Health